Common Contracts

COMMON STOCK PURCHASE WARRANT MALACHITE INNOVATIONS, Inc.

Common Stock Purchase Warrant • April 13th, 2023 • Malachite Innovations, Inc. • Services-commercial physical & biological research

• Contract Type
  Common Stock Purchase Warrant
• Filed
  April 13th, 2023
• Company
  Malachite Innovations, Inc.
• Industry
  Services-commercial physical & biological research

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [x] or [his/her/its] assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date,” such period from the Initial Exercise Date to the Termination Date, the “Exercise Period”) but not thereafter, to subscribe for and purchase from Malachite Innovations, Inc., a Nevada corporation (the “Company”), up to [x] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT DIFFUSION PHARMACEUTICALS INC.

Common Stock Purchase Warrant • March 15th, 2017 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations

• Contract Type
  Common Stock Purchase Warrant
• Filed
  March 15th, 2017
• Company
  Diffusion Pharmaceuticals Inc.
• Industry
  Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the final closing date of the Offering (the “Termination Date”) but not thereafter, to subscribe for and purchase from Diffusion Pharmaceuticals Inc., a Delaware corporation (the “Company”), up to ______1 shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”).